在2008-2022年期间在美国进行前列腺特异性抗原测试,与美国预防服务工作组建议相关
Ray M Merrill1, Ian S Gibbons2
1Department of Public Health, College of Life Sciences, Brigham Young University, 2063 Life Sciences Building, Provo, UT, 84602, USA. Ray_Merrill@byu.edu.
Scientific reports
|December 29, 2024
概括
前列腺特异性抗原 (PSA) 测试在2020年之前大幅下降,然后因指导方针和患者因素的影响而上升. 测试率因年龄,婚姻状况,教育和保险而异,常规考试是主要的驱动因素.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 近年来,前列腺特异性抗原 (PSA) 测试的流行率呈现下降趋势.
- 了解这一趋势中的人口和社会经济变化对于公共卫生倡议至关重要.
研究的目的:
- 分析从2008年到2022年PSA测试率的趋势.
- 调查这些趋势在各种人口和社会经济变量之间如何不同.
- 探索PSA测试普及的原因及其与患者特征的关联.
主要方法:
- 对行为风险因素监测系统 (BRFSS) 调查数据的分析.
- 包括40岁及以上的男性在偶数年 (2008-2022) 接受调查.
- 检查PSA测试率,人口因素和自我报告的测试原因.
主要成果:
- 从2008年到2020年,PSA测试率下降了46%,随后从2020年到2022年,PSA测试率增加了21%,这与USPSTF指导方针变化相吻合.
- 在年轻,未婚,受教育程度较低,没有保险的男性中,下降更为明显.
- 观察到与指导方针的不一致性,年龄较大和受过更高教育的男性的测试率更高;例行检查是测试的主要原因.
结论:
- PSA 测试趋势是动态的,并受到不断变化的指导方针和患者特定因素的影响.
- 在人口和社会经济层面之间存在测试的差异,特别是在例行查方面.
- 需要进一步的研究来解决不一致性,并优化PSA查策略.
更多相关视频
05:32Povidone Iodine Rectal Preparation at Time of Prostate Needle Biopsy is a Simple and Reproducible Means to Reduce Risk of Procedural Infection
Published on: September 21, 2015
32.1K
05:25Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
Published on: August 14, 2019
19.1K
相关概念视频
01:20Disorders of the Male Reproductive System
319
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
319
01:30Cancer Vaccines
338
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
338